Keep Canadian drugs out of U.S. medicine cabinets

Photo Credit: Alexander Hunter/Washington Times

The Trump administration recently proposed two rules that would allow states, pharmacies and drug wholesalers to import non-FDA approved medicines from Canada.

No administration, Republican or Democratic, has ever allowed Canadian drug importation — and for good reason. First, experts agree that such a scheme wouldn’t reduce by one penny the co-pay of a single American. Second, it would expose Americans to dangerous counterfeit medicines.

Fortunately, these rules haven’t been finalized. The Department of Health and Human Services and the FDA are accepting comments on the proposals until March 9. Patients and pharmacists can help stop these misguided importation schemes by flooding HHS and the FDA with comments that tell the truth rather than pander to political talking points.


 
Sign Up for Our Email Newsletter

RECENT NEWS

Qualifying Single-Source Drug Policy, Medicare Price Negotiation, and the Incentives for Meaningful Post-Approval Innovation

Qualifying Single-Source Drug Policy, Medicare Price Negotiation, and the Incentives for Meaningful Post-Approval Innovation

CMS should demand evidence from manufacturers and be prepared to defend its own assumptions about innovation. Its next st...  Read more

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

Authors argue that rare disease innovation requires learning more from fewer patients—not enrolling more patients...  Read more

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Texas has an opportunity to lead rather than react. Better measurement would strengthen public confidence without diminis...  Read more

DRUGWONKS BLOG